Abstract

 Cord blood (collected from the cord and placenta at birth) is a very rich source of fetal haemoglobin, CD34+ haemopoietic stem cells, cytokines and platelets. Fetal haemoglobin, in cord blood erythrocytes, has been used to treat severe anaemia has been reported to have an anti-malarial effect. Nigeria has a wide gap in the provision of safe blood through the WHO approved voluntary and altruistic donation, cord blood transfusion could play a significant role in bridging this gap. Current cord blood collections are a relatively low in volume and this is a potential disadvantage of cord blood transfusion. This can be overcome by multiple transfusions and also by future improvements in collection technology. The National Blood Transfusion Services of Nigeria (NBTS) and other stake holders need to further evaluate and exploit this life saving opportunity through a coherent plan and infrastructure for the creation of a clinically useful cord blood donation programmed across Nigeria. This would result in a massive improvement in the general health and reduce morbidity and mortality in Nigeria. An implementation process is proposed for the introduction of cord blood transfusion in Nigeria.

Keywords: Cord Blood Transfusion; Nigeria; CD34+

References

1. Sloand EM., et al. “Safety of blood supply”. The Journal of the American Medical Association 274 (1995):1368-1373.
2. Bhattacharya N. “A preliminary study of placental umbilical cord whole blood transfusion in under re-sourced patients with malaria in the background of anaemia”. Malaria Journal 5 (2006a): 20.
3. Shearer WT., et al. “Cord blood banking for future transplantation”. Pediatrics 140 (2017): 2695.
4. Roura S and Vives J. “Extracellular vesicles: Squeezing every drop of regenerative potential of umbilical cord blood”. Metabolism 95 (2019): 102-104.
5. Halbrecht J. “Transfusion with placental blood”. Lancet 263 (1939): 202-203.
6. Paxson CL. “Collection and use of autologous fetal blood”. American Journal of Obstetrics and Gynecology 134 (1979): 708-710.
7. Piacibello W., et al. “Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood”. Blood 89 (1997): 2644-2653.
8. Brandes JM., et al. “Collection and preservation of human placental blood”. Transfusion 23 (1983): 327-327.
9. Bhattacharya N. “A preliminary report of 123 units of placental umbilical cord whole blood transfusion in HIV-positive patients with anemia and emaciation”. Clinical and Experimental Obstetrics and Gynecology 33 (2006b): 117-121.
10. Bhattacharya N. “Placental umbilical cord blood transfusion in transfusion-dependent beta thalassemic patients: a preliminary communication”. Clinical and Experimental Obstetrics and Gynecology 32 (2005a): 102-106.
11. Bhattacharya N. “Placental umbilical cord blood transfusion. A new method of treatment of patients with diabetes and microalbuminuria in the background of anemia”. Clinical and Experimental Obstetrics and Gynecology 33 (2006c): 164-168.
12. Bhattacharya N. “Placental umbilical cord whole blood transfusion to combat anemia in the background of advanced rheumatoid arthritis and emaciation and its potential role as immuno adjuvant therapy”. Clinical and Experimental Obstetrics and Gynecology 33 (2006d): 28-33.
13. Bhattacharya N. “Placental umbilical cord whole blood transfusion to combat anemia in the background of tuberculosis and emaciation and its potential role as an immuno-adjuvant therapy for the under-resourced people of the world”. Clinical and Experimental Obstetrics and Gynecology 33 (2006e): 99-104.
14. Bhattacharya N. “Transient spontaneous engraftment of CD34 hematopoietic cord blood stem cells as seen in peripheral blood: treatment of leprosy patients with anemia by placental umbilical cord whole blood trans-fusion”. Clinical and Experimental Obstetrics and Gynecology 33 (2006f):159-163.
15. Ramsey G. “Blood component transfusions in mass casualty events”. Vox Sanguinis 112 (2017): 648-659.
16. Perez A., et al. “Overtransfusion of Autologous Blood Identifies Opportunities for Improving Patient Blood Management”. Cureus 11 (2019): e4202.
17. Oyekunle AA. “Haemopoietic Stem Cell Transplantation: Prospects and Challenges in Nigeria”. Annals of Ibadan Postgraduate Medicine (2006): 4.
18. Shear HL., et al. “Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism”. Blood 92 (1998): 2720-2726.
19. Ramirez-Arcos S., et al. “Validation of sterility testing of cord blood: challenges and results”. Transfusion 55 (2015): 1985-1992.
20. Wong A., et al. “Cord blood collection before and after placental delivery: levels of nucleated cells, haematopoietic progenitor cells, leukocyte subpopulations and macroscopic clots”. Bone Marrow Trans 27 (2001): 133-138.
21. Faivre L., et al. “Associated factors of umbilical cord blood collection quality”. Transfusion 58 (2018): 520-531.
22. Berglund S., et al. “Advances in umbilical cord blood cell therapy: the present and the future”. Expert Opinion on Biological Therapy 17 (2017): 691-699.
23. Santos SV., et al. “Predictors of high-quality cord blood units”. Transfusion 56 (2016): 2030-2036.
24. Bassiouny MR., et al. “Optimal method for collection of umbilical cord blood: an Egyptian trial for a public cord blood bank”. Transfusion 55 (2015): 1263-1268.
25. Adewumi A., et al. “Cord blood full blood count parameters in Lagos, Nigeria”. The Pan African Medical Journal17 (2014): 192-196.
26. Pasquini MC., et al. “Worldwide Network for Blood and Mar-row Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond”. Biology of Blood and Marrow Transplantation (2019):1083-8791.
27. Bhattacharya N., et al. “A study report of 174 units of placental umbilical cord whole blood transfusion in 62 patients as a rich source of fetal hemoglobin supply in different indications of blood transfusion”. Clinical and Experimental Obstetrics and Gynecology 28 (2001): 47-52.
28. Bhattacharya N. “Placental umbilical cord whole blood transfusion: a safe and genuine blood substitute for patients of the under-resourced world at emergency”. Journal of the American College of Surgeons 2205 (2005b): 557-563.
29. Hassall O., et al. “The quality of stored umbilical cord and adult-donated whole blood in Mombasa, Ken-ya”. Transfusion 50 (2010): 611-616.
30. Jawat D., et al. “Improving cord blood unit quantity and quality at King Abdullah International Medical Research Center Cord Blood Bank”. Transfusion 54 (2014): 3127-3130.
31. Tan KK., et al. “Ex utero harvest of hematopoietic stem cells from placenta/umbilical cord with an automated collection system”. IEEE Transactions on Biomedical Engineering 56 (2009): 2331-2334.
32. Takebe N., et al. “Preliminary findings on the use of pulsatile machine re-perfusion of a placenta to improve the cord blood collection yield including primitive hematopoietic stem cell fractions”. Transfusion 49 (2009):1911-1916.
33. Fernandez A and Chasovski K. “The Use of Umbilical Cord Blood for Autologous Transfusion in Neonatal Open Heart Surgery”. Journal of Cardiothoracic and Vascular Anesthesia (2019).
34. Michelle C. “Media(ted) fabrications: how the science-media symbiosis helped 'sell' cord banking”. Communication and Medicine 3 (2006): 55-68.
35. Petrini C. “Umbilical cord blood collection, storage and use: ethical issues”. Blood Transfusion 8 (2010): 139-148.
36. Armson BA., et al. “Umbilical Cord Blood: Counselling, Collection, and Banking”. Journal of Obstetrics and Gynaecology Canada 37 (2015): 832-844.
37. Hollands P and McCaully C. “Private cord blood banking: Current use and clinical future”. Stem Cell Reviews and Reports 3 (2009): 195-203.
38. Kuliya-Gwarzo A and Kwaru A. “Pattern of Blood Donation in Aminu Kano Teaching Hospital”. Journal of Rehabilitation Medicine 1 (2007): 1-10.
39. Akinbami A., et al. “The Prevalence of Occult Hepatitis B Infection among Blood Donors in Lagos, Nigeria”. Journal of the Nigeria Medical Association 60 (2019): 22-26.
40. Okafor CB and Rizzuto RR. “Women's and health-care providers' views of maternal practices and services in rural Nigeria”. Studies in Family Planning 25 (1994): 353-361.
41. Sekoni AO., et al. “Blood donation practices and willingness to donate among residents of an urban slum in Lagos Nigeria”. Nigerian Postgraduate Medical Journal 21 (2014): 21-27.
42. Aneke JC and Okocha CE. “Blood transfusion safety; current status and challenges in Nigeria”. Asian Journal of Transfusion Science 11 (2017): 1-5.
43. Benedict N., et al. “Blood donation in Nigeria: standard of the donated blood”. Journal of Laboratory Physicians 4 (2012): 94-97.
44. Musa BM., et al. “Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: a systematic review and meta-analysis”. Nigerian Journal of Clinical Practice 18 (2015): 163-172.
45. Muktar HM., et al. “Safety of blood transfusion: prevalence of Hepatitis B surface antigen in blood donors in Zaria, Northern Nigeria”. The Nigerian Journal of Surgical Research 34 (2005): 290-292.
46. Ahmed SG., et al. “Adequacy and pattern of blood donations in north-eastern Nigeria: the implications for blood safety”. Annals of Tropical Medicine and Parasitology 101 (2008): 727-731.
47. Ahmed SG., et al. “The Burden of HIV and AIDS on Blood Bank Reserve in North East Nigeria”. Transactions of the Royal Society of Tropical Medicine and Hygiene 101 (2007): 618-620.

Citation

Citation: P Hollands., et al. “Prospects and Challenges of Cord Blood Transfusion in Nigeria". Acta Scientific Biotechnology 1.7 (2020): 09-14.

Copyright

Copyright: © 2020 P Hollands., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.